Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.
about
The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model."Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in miceIn vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
P2860
Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel 3-substituted rimonabant ...... d behavioural effects in mice.
@en
type
label
Novel 3-substituted rimonabant ...... d behavioural effects in mice.
@en
prefLabel
Novel 3-substituted rimonabant ...... d behavioural effects in mice.
@en
P2093
P2860
P356
P1476
Novel 3-substituted rimonabant ...... d behavioural effects in mice.
@en
P2093
P2860
P356
10.1111/BPH.12099
P407
P577
2013-05-01T00:00:00Z